Overview
Join us as at the DIA Japan Annual Meeting 2019, to discuss these topics and the future of healthcare.
At DIA, we are here to continue challenging by exerting leadership with a collaboration among industry, government and academia to create a new value in pharmaceutical and medical device development. Needless to say, how to work effectively together is as important as the individual leadership. By maintaining ethics, transparency and fairness, avoiding the conflict of interest and enabling the synergism, a better rational collaboration can be achieved. As a result, our goal is to provide rational medicine with breakthrough innovation to all the current and future people. The 16th DIA Japan Annual Meeting, with a theme of “In Order to Deliver Rational Medicine to all the people in the world,” is a place for discussion, thinking and opinion exchange to contribute to medical environment in the future.
We look forward to welcoming you at Tokyo Big Sight from November 10-12, 2019 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.
Program Committee
-
Tatsuya Kondo, MD, PhD President
SH Medical Excellence JAPAN, Japan -
Takashi Sato, MSc, PMP
PM Orchestra Takashi Sato, Japan -
Hiroya Asou, MD, PhD, MBA Senior Medical Advisor, Global Patient Safety Japan
Eli Lilly Japan K.K., Japan -
Noriko Fujiwara, MS, RN Certified nurse specialist in Cancer Nursing
IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan -
Yoshikata Furuya, MSc Manager, General Affairs Division
Sankeien Hoshoukai Foundation, Japan -
Toshinori Higashi, PhD Vice President, Regulatory Science
KAKEN PHARMACEUTICAL CO.,LTD., Japan -
Kazuo Ichikawa, PhD, PMP yyy
Xxx, Japan -
Katsuhiko Ichimaru Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?